0001144204-14-005049.txt : 20140130 0001144204-14-005049.hdr.sgml : 20140130 20140130172621 ACCESSION NUMBER: 0001144204-14-005049 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140130 DATE AS OF CHANGE: 20140130 EFFECTIVENESS DATE: 20140130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-211038 FILM NUMBER: 14561652 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 D 1 primary_doc.xml X0707 D LIVE 0001549084 EKSO BIONICS HOLDINGS, INC. 1414 HARBOUR WAY SOUTH SUITE 1201 RICHMOND CA CALIFORNIA 94804 510-984-1761 NEVADA PN Med Group, Inc. PN Med Group Inc Corporation true 2012 Nathan Harding 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Director Chief Executive Officer and President Daniel Boren 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Frank Moreman 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Chief Operating Officer Russ Angold 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Chief Technology Officer Marilyn Hamilton 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Max Scheder-Bieschin 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Chief Financial Officer, Treasurer and Secretary Steven Sherman 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Jack Peurach 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Other Technology Decline to Disclose 06b false 2014-01-15 false true true true true Common stock, warrants to purchase common stock and stock options. true Pursuant to Agreement and Plan of Merger, Issuer issued 42,615,546 shares of Common Stock ("CS") to shareholders of Ekso Bionics, Inc. ("Ekso") and warrants to purchase 3,365,012 shares of CS and options to purchase 7,586,459 shares of CS. 0 50794281 50794281 0 Represents aggregate value of 42,615,546 shares of Common Stock ("CS") at $1/share; 3,365,012 warrants to purchase CS at an exercise price of $1.3781/share; and 7,586,459 options to purchase CS with a weighted average exercise price of $0.46/share. true 30 110 0 0 0 false EKSO BIONICS HOLDINGS, INC. /s/ Nathan Harding Nathan Harding Chief Executive Officer and President 2014-01-30